Workflow
海王生物(000078) - 2022 Q3 - 季度财报
NEPTUNUSNEPTUNUS(SZ:000078)2022-10-27 16:00

Financial Performance - The company's revenue for Q3 2022 was ¥10,834,403,428.71, an increase of 2.82% compared to the same period last year[7]. - Net profit attributable to shareholders was ¥18,162,405.63, a decrease of 75.28% year-on-year[7]. - The net profit after deducting non-recurring gains and losses was ¥14,652,414.34, down 75.88% from the previous year[7]. - Total operating revenue for the current period is ¥28,955,751,861.94, a decrease of 5.93% from ¥30,775,630,066.91 in the previous period[29]. - Net profit for the current period is ¥218,156,601.74, a decline of 37.94% compared to ¥351,745,607.06 in the previous period[29]. - Basic earnings per share for the current period is ¥0.0480, down from ¥0.0777 in the previous period[32]. Assets and Liabilities - The total assets at the end of the reporting period were ¥36,745,760,034.24, a decrease of 2.28% from the end of the previous year[7]. - As of September 30, 2022, the company's total assets amounted to RMB 36,745,760,034.24, a decrease from RMB 37,603,849,419.61 at the beginning of the year[19]. - The total liabilities amounted to RMB 30,877,441,775.55, compared to RMB 31,616,610,446.47 at the beginning of the year[22]. - The total liabilities amount to ¥29,347,901,341.81, down from ¥30,295,590,943.09 in the previous period[29]. Cash Flow - The company’s cash flow from operating activities for the year-to-date was ¥631,812,732.98, a decrease of 44.12% compared to the previous year[7]. - The net cash flow from operating activities for Q3 2022 was ¥631,812,732.98, a decrease from ¥1,130,606,278.79 in Q3 2021, indicating a decline of approximately 44.2%[35]. - Total cash inflow from operating activities was ¥2,324,209,213.98, while cash outflow was ¥32,496,592,193.40, resulting in a significant cash outflow[35]. - The ending balance of cash and cash equivalents was ¥359,743,994.20, down from ¥1,490,498,412.18 at the beginning of the period, reflecting a decrease of approximately 75.8%[35]. Investments and Financing - Long-term borrowings increased by 37.26% compared to the beginning of the year, indicating an increase in long-term financing[13]. - The company reported a total cash inflow from financing activities of ¥17,350,468,225.70 in Q3 2021, indicating a year-over-year decrease of approximately 43.1%[35]. - Cash inflow from financing activities totaled ¥9,857,263,109.04, while cash outflow was ¥10,685,481,618.36, leading to a net cash flow of -¥828,218,509.32[35]. Operational Changes - The company is planning a significant asset restructuring and mixed ownership reform, with due diligence completed and discussions ongoing regarding specific transaction plans[18]. - The company has engaged intermediary institutions for the major asset restructuring, ensuring compliance with legal and regulatory requirements for information disclosure[18]. - The company is focusing on improving cash flow management and reducing operational costs in response to the declining cash flow figures[35]. Other Financial Metrics - The weighted average return on net assets was 0.30%, down 0.94% year-on-year[7]. - Other income grew by 105.68% year-on-year, primarily due to an increase in government subsidies received[13]. - The company experienced a 561.87% increase in fair value losses compared to the same period last year, attributed to changes in the fair value of payable equity from minority shareholders[13]. - Research and development expenses for the current period are ¥37,669,721.48, down from ¥48,647,713.09 in the previous period[29]. - Financial expenses for the current period are ¥467,180,747.40, a decrease from ¥634,327,177.36 in the previous period[29]. - The company did not conduct an audit for the Q3 report, which may affect the reliability of the financial data presented[39].